ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,000 | +50.0% | 11,825 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | +20.0% | 11,825 | -20.2% | 0.00% | – |
| Q1 2020 | $5,000 | -50.0% | 14,825 | +0.2% | 0.00% | – |
| Q4 2019 | $10,000 | 0.0% | 14,800 | +5.7% | 0.00% | – |
| Q3 2019 | $10,000 | -44.4% | 14,000 | 0.0% | 0.00% | – |
| Q2 2019 | $18,000 | -40.0% | 14,000 | 0.0% | 0.00% | – |
| Q1 2019 | $30,000 | -14.3% | 14,000 | -9.6% | 0.00% | – |
| Q4 2018 | $35,000 | -55.7% | 15,490 | -31.4% | 0.00% | – |
| Q3 2018 | $79,000 | +14.5% | 22,590 | +4.6% | 0.00% | – |
| Q2 2018 | $69,000 | -9.2% | 21,590 | 0.0% | 0.00% | – |
| Q1 2018 | $76,000 | +46.2% | 21,590 | +83.1% | 0.00% | – |
| Q4 2017 | $52,000 | -23.5% | 11,790 | -8.9% | 0.00% | – |
| Q3 2017 | $68,000 | -13.9% | 12,940 | -15.1% | 0.00% | – |
| Q2 2017 | $79,000 | – | 15,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |